Contract Development & Manufacturing Operations (CDMO)

Contract Development & Manufacturing Operations (CDMO)
Product Description

Nabiqasim Pharma Group offers integrated Contract Development & Manufacturing Operations (CDMO) for pharmaceutical companies seeking a reliable partner for Branded Generic Formulations. Our capabilities include Prostaglandins, Laxatives/Enemas, Lyophilized Infusions, Tablets & Capsules, Liquids & Suspensions, Creams & Lotions, and Injectables/Respules. We support partners from formulation development, technology transfer and scale-up through commercial manufacturing and supply. Our regulatory services include dossier preparation and registration support in eCTD format, along with analytical and stability support. Manufacturing operations are supported by robust quality systems and facilities aligned with cGMP, ANVISA, PIC/S and ICH-Q7 requirements.

Read more Show less

Nabiqasim Pharma Group

  • Country/Region:
    Pakistan
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    International Regulatory Approvals including ANVISA, PIC/S, cGMP as per WHO guidelines 
  • Model
    CDMO
  • Supplied from
    Pakistan
More specifications Fewer specifications
Sales Markets
Show more Show less

Nabiqasim Pharma Group

  • Country/Region:
    Pakistan
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile

More Products from Nabiqasim Pharma Group (3)

  • Cardiovascular

    Product Cardiovascular

    Nabiqasim offers a wide range of Cardiovascular products in combination and single ingredient including APIXABAN; RIVIROXABAN; SACUBITRIL+VALSARTAN; ROSUVASTATIN+EZETIMIBE and many others. 
  • Hypoglycemics

    Product Hypoglycemics

    Nabiqasim offers a wide range of Hypoglycemic products including DAPAGLIFLOZIN+METFORMIN HYDROCHLORIDE EXTENDED RELEASE; EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE;  EMPAGLIFLOZIN+LINAGLIPTIN+METFORMIN HYDROCHLORIDE EXTENDED RELEASE and many others
  • Lyophilization (ANVISA APPROVED) / Hormonal Section /Dydrogesterone (PIC/S APPROVED)

    Product Lyophilization (ANVISA APPROVED) / Hormonal Section /Dydrogesterone (PIC/S APPROVED)

    Lyophilized vials

Nabiqasim Pharma Group resources (1)

  • PIC/S and ANVISA Approval

    News PIC/S and ANVISA Approval

    Nabiqasim Pharma proudly announces the successful accreditation of its Injectable & Lyophilized Section by ANVISA and Hormonal Solid Dosage Manufacturing Section by PIC/S. 
    10 Oct 2025